cdk2 inhibitors (Vernalis)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namecdk2 inhibitors (Vernalis)
Drug Alias NameRBT-0049985VER-54505
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 2 inhibitorsAnticancer protein kinase inhibitors
TargetsCyclin-dependent kinase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVernalis Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVernalis Plc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A